Skip to Main Content
TRC_Tech_Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • New Drugs
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Infectious Diseases
  4. HIV & AIDS
  5. Treatment

Treatment

  • Antimicrobial Stewardship (18)
  • COVID-19 (41)
  • Fever (5)
  • Fungal Infections (11)
  • H1N1 (Swine) Influenza (39)
  • HIV & AIDS (67)
    • Drug-Induced Toxicity (7)
    • Drug Interactions (12)
    • HIV Screening and Testing (10)
    • Opportunistic Infection Drug Therapies (4)
    • Prevention (30)
    • Treatment (24)
      • Antiviral Drug Therapies (22)
      • Selecting a Treatment Regimen (16)
  • Infections (55)
  • Lower Respiratory Tract Infections (98)
  • Measles (3)
  • MRSA (6)
  • Other (159)
  • Resources (430)
  • STIs (80)
  • Skin/Soft Tissue Infections (55)
  • Thrush (2)
  • Travel Medicine (64)
  • Upper Respiratory Tract Infections (153)
  • Vaccines (230)
  • West Nile Virus (8)
1 - 15 of 24 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: New Drugs: Vocabria (Cabotegravir) and Cabenuva (Cabotegravir/Rilpivirine) November 2020
Article: Get Ready for the Once-Monthly Injectable HIV Med, Cabenuva November 2020
Chart: New Formulation: Dovato (Dolutegravir-Lamivudine) November 2019
Article: Be Prepared to Dispense Dovato, a New Combo Med for HIV November 2019
Chart: Primary Prophylaxis of Opportunistic Infections in HIV June 2019
Chart: New Drug: Biktarvy (Bictegravir/Emtricitabine/Tenofovir Alafenamide) October 2018
Chart: New Drug: Juluca (Dolutegravir/Rilpivirine) October 2018
Article: Expect to See More HIV Meds Containing "Integrase Inhibitors" October 2018
Commentary: Symtuza Approved in Canada June 2018
Guideline: Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV, 2018 June 2018
Article: Symtuza and Biktarvy Will Join Other Combos for Treating HIV June 2018
Checklist: HIV Patient Transitions of Care Checklist May 2017
Article: Watch for HIV Patients Getting Both the Old and New Forms of Tenofovir September 2016
Other: General Principles of HIV Drug Therapy for Pharmacy Technicians September 2016
Other: HIV Drug Therapy Update for Pharmacy Technicians September 2016
  • 1
  • 2
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved